Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded. [Operator instructions] I would now like to turn the call over to Mr. Peter ...

Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 EPS, expectations were $1.85. Operator: Thank you for standing by. Welcome to ...

Arrow Therapeutics focused exclusively on novel antiviral drug discovery and development, including several different approaches towards Hepatitis C and Respiratory Syncytial Virus (RSV).

Pfizer - Pfizer has invested USD 1.5 billion in mRNA technology, aiming to develop vaccines for flu, HIV, and RSV. Additionally ... AstraZeneca - AstraZeneca formed a partnership with Daiichi Sankyo ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical ...

Professor of Paediatrics and vaccinologist, Royal Childrens Hospital, University of Melbourne and Murdoch Childrens Research Institute (MCRI); Associate Dean International, University of Melbourne ...

(MENAFN- The Conversation) From today, February 3 , pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation Program . This vaccine is designed to ...

Pregnant women across the Northern Territory now have free access to protection against a virus that is the leading cause of hospitalisation for babies. The federal government is investing $174.5m ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation Program. This vaccine is designed to protect young infants from severe ...

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory syncytial virus (RSV) - a cold-like illness that can make some people ...